世界のアルコール性肝炎治療市場規模・現状・予測2021-2027

【英語タイトル】Global Alcoholic Hepatitis Therapeutic Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR0235)・商品コード:QY21APR0235
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:91
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、アルコール性肝炎治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(モノクローナル抗体、カスパーゼプロテアーゼ阻害剤、コルチコステロイド、血液レオロジー剤、アナボリックステロイド、肝向性ホルモン、スルフヒドリル剤、その他)、用途別市場規模(病院・クリニック、研究・開発)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・アルコール性肝炎治療の市場動向
・企業の競争状況、市場シェア
・アルコール性肝炎治療の種類別市場規模(モノクローナル抗体、カスパーゼプロテアーゼ阻害剤、コルチコステロイド、血液レオロジー剤、アナボリックステロイド、肝向性ホルモン、スルフヒドリル剤、その他)
・アルコール性肝炎治療の用途別市場規模(病院・クリニック、研究・開発)
・アルコール性肝炎治療の北米市場規模2016-2027(アメリカ、カナダ)
・アルコール性肝炎治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・アルコール性肝炎治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・アルコール性肝炎治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・アルコール性肝炎治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Alkermes、Conatus pharmaceuticals、Dainippon sumitomo pharma、Generon corporation、Immuron limited、Lupin Laboratories、Intercept Pharmaceuticals、Teva Pharmaceuticals、Sanofi-Aventis)
・結論
【レポートの概要】

Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is used to describe the acute onset of symptomatic hepatitis. Symptoms include changes I appetite, dry mouth, yellowing of skin or eyes, weight loss, fever and fatigue. Sometime alcoholic hepatitis could get serious conditions include fluid buildup in the abdomen, confusion or brain fog and bleeding in esophagus or stomach. Treatment for alcoholic hepatitis involves therapies and drinking cessation to ease the sign and symptoms of liver damage. Corticosteroids are the current main treatment for alcoholic hepatitis in patients who do not have contraindication for steroid treatment. Corticosteroids are the medications have shown short-term benefits in increasing survival of certain people suffer with alcoholic hepatitis. Pentoxifylline is recommend to patients who can’t take corticosteroids. Studies indicate that pentoxifylline might not be effective for people with mild alcoholic hepatitis or people who have not respond to steroid treatment.
The global alcoholic hepatitis therapeutics market is expected to witness a favorable growth during the forecast period. Increasing incidence of liver diseases and high success rate of pipeline drugs are the major factors which increase global alcoholic hepatitis market. Moreover high adoption rate for novel therapeutic products and increasing prevalence of alcoholic liver disease are some other factors that are expected to fuel the demand of global alcoholic hepatitis market. Global alcoholic hepatitis market shows potential to be expanding and lucrative field due to increasing merger and acquisitions among pharmaceutical companies to develop advance therapies for treating liver diseases. Furthermore, increased focus on retaining best quality of life is one the factor contributing to the growth of the market. However increasing health care expenditure, stringent reimbursement policies and high development cost are some factors that might hinder the growth of alcoholic hepatitis therapeutics market in forecast period.

Market Analysis and Insights: Global Alcoholic Hepatitis Therapeutic Market
The global Alcoholic Hepatitis Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Alcoholic Hepatitis Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Alcoholic Hepatitis Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Alcoholic Hepatitis Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Alcoholic Hepatitis Therapeutic market.

Global Alcoholic Hepatitis Therapeutic Scope and Market Size
Alcoholic Hepatitis Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Alcoholic Hepatitis Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monoclonal Antibodies
Caspase Protease Inhibitor
Corticosteroids
Hemorheologic Agents
Anabolic Steroids
Hepatotropic Hormones
Sulfhydryl Agents
Others

Segment by Application
Hospitals and Clinics
Research and Development

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Alkermes
Conatus pharmaceuticals
Dainippon sumitomo pharma
Generon corporation
Immuron limited
Lupin Laboratories
Intercept Pharmaceuticals
Teva Pharmaceuticals
Sanofi-Aventis

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Caspase Protease Inhibitor
1.2.4 Corticosteroids
1.2.5 Hemorheologic Agents
1.2.6 Anabolic Steroids
1.2.7 Hepatotropic Hormones
1.2.8 Sulfhydryl Agents
1.2.9 Others
1.3 Market by Application
1.3.1 Global Alcoholic Hepatitis Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Research and Development
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Alcoholic Hepatitis Therapeutic Market Perspective (2016-2027)
2.2 Alcoholic Hepatitis Therapeutic Growth Trends by Regions
2.2.1 Alcoholic Hepatitis Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Alcoholic Hepatitis Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Alcoholic Hepatitis Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Alcoholic Hepatitis Therapeutic Industry Dynamic
2.3.1 Alcoholic Hepatitis Therapeutic Market Trends
2.3.2 Alcoholic Hepatitis Therapeutic Market Drivers
2.3.3 Alcoholic Hepatitis Therapeutic Market Challenges
2.3.4 Alcoholic Hepatitis Therapeutic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Alcoholic Hepatitis Therapeutic Players by Revenue
3.1.1 Global Top Alcoholic Hepatitis Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Alcoholic Hepatitis Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Alcoholic Hepatitis Therapeutic Revenue
3.4 Global Alcoholic Hepatitis Therapeutic Market Concentration Ratio
3.4.1 Global Alcoholic Hepatitis Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alcoholic Hepatitis Therapeutic Revenue in 2020
3.5 Alcoholic Hepatitis Therapeutic Key Players Head office and Area Served
3.6 Key Players Alcoholic Hepatitis Therapeutic Product Solution and Service
3.7 Date of Enter into Alcoholic Hepatitis Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Alcoholic Hepatitis Therapeutic Breakdown Data by Type
4.1 Global Alcoholic Hepatitis Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Type (2022-2027)

5 Alcoholic Hepatitis Therapeutic Breakdown Data by Application
5.1 Global Alcoholic Hepatitis Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Alcoholic Hepatitis Therapeutic Market Size (2016-2027)
6.2 North America Alcoholic Hepatitis Therapeutic Market Size by Type
6.2.1 North America Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2027)
6.3 North America Alcoholic Hepatitis Therapeutic Market Size by Application
6.3.1 North America Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2027)
6.4 North America Alcoholic Hepatitis Therapeutic Market Size by Country
6.4.1 North America Alcoholic Hepatitis Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Alcoholic Hepatitis Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Alcoholic Hepatitis Therapeutic Market Size (2016-2027)
7.2 Europe Alcoholic Hepatitis Therapeutic Market Size by Type
7.2.1 Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2027)
7.3 Europe Alcoholic Hepatitis Therapeutic Market Size by Application
7.3.1 Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2027)
7.4 Europe Alcoholic Hepatitis Therapeutic Market Size by Country
7.4.1 Europe Alcoholic Hepatitis Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Alcoholic Hepatitis Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Type
8.2.1 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Application
8.3.1 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Region
8.4.1 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Alcoholic Hepatitis Therapeutic Market Size (2016-2027)
9.2 Latin America Alcoholic Hepatitis Therapeutic Market Size by Type
9.2.1 Latin America Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Alcoholic Hepatitis Therapeutic Market Size by Application
9.3.1 Latin America Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Alcoholic Hepatitis Therapeutic Market Size by Country
9.4.1 Latin America Alcoholic Hepatitis Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Alcoholic Hepatitis Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Type
10.2.1 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Application
10.3.1 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Country
10.4.1 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Alkermes
11.1.1 Alkermes Company Details
11.1.2 Alkermes Business Overview
11.1.3 Alkermes Alcoholic Hepatitis Therapeutic Introduction
11.1.4 Alkermes Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021)
11.1.5 Alkermes Recent Development
11.2 Conatus pharmaceuticals
11.2.1 Conatus pharmaceuticals Company Details
11.2.2 Conatus pharmaceuticals Business Overview
11.2.3 Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction
11.2.4 Conatus pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021)
11.2.5 Conatus pharmaceuticals Recent Development
11.3 Dainippon sumitomo pharma
11.3.1 Dainippon sumitomo pharma Company Details
11.3.2 Dainippon sumitomo pharma Business Overview
11.3.3 Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Introduction
11.3.4 Dainippon sumitomo pharma Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021)
11.3.5 Dainippon sumitomo pharma Recent Development
11.4 Generon corporation
11.4.1 Generon corporation Company Details
11.4.2 Generon corporation Business Overview
11.4.3 Generon corporation Alcoholic Hepatitis Therapeutic Introduction
11.4.4 Generon corporation Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021)
11.4.5 Generon corporation Recent Development
11.5 Immuron limited
11.5.1 Immuron limited Company Details
11.5.2 Immuron limited Business Overview
11.5.3 Immuron limited Alcoholic Hepatitis Therapeutic Introduction
11.5.4 Immuron limited Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021)
11.5.5 Immuron limited Recent Development
11.6 Lupin Laboratories
11.6.1 Lupin Laboratories Company Details
11.6.2 Lupin Laboratories Business Overview
11.6.3 Lupin Laboratories Alcoholic Hepatitis Therapeutic Introduction
11.6.4 Lupin Laboratories Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021)
11.6.5 Lupin Laboratories Recent Development
11.7 Intercept Pharmaceuticals
11.7.1 Intercept Pharmaceuticals Company Details
11.7.2 Intercept Pharmaceuticals Business Overview
11.7.3 Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction
11.7.4 Intercept Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021)
11.7.5 Intercept Pharmaceuticals Recent Development
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Details
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction
11.8.4 Teva Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021)
11.8.5 Teva Pharmaceuticals Recent Development
11.9 Sanofi-Aventis
11.9.1 Sanofi-Aventis Company Details
11.9.2 Sanofi-Aventis Business Overview
11.9.3 Sanofi-Aventis Alcoholic Hepatitis Therapeutic Introduction
11.9.4 Sanofi-Aventis Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021)
11.9.5 Sanofi-Aventis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Caspase Protease Inhibitor
Table 4. Key Players of Corticosteroids
Table 5. Key Players of Hemorheologic Agents
Table 6. Key Players of Anabolic Steroids
Table 7. Key Players of Hepatotropic Hormones
Table 8. Key Players of Sulfhydryl Agents
Table 9. Key Players of Others
Table 10. Global Alcoholic Hepatitis Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Alcoholic Hepatitis Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Alcoholic Hepatitis Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Alcoholic Hepatitis Therapeutic Market Share by Regions (2016-2021)
Table 14. Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Alcoholic Hepatitis Therapeutic Market Share by Regions (2022-2027)
Table 16. Alcoholic Hepatitis Therapeutic Market Trends
Table 17. Alcoholic Hepatitis Therapeutic Market Drivers
Table 18. Alcoholic Hepatitis Therapeutic Market Challenges
Table 19. Alcoholic Hepatitis Therapeutic Market Restraints
Table 20. Global Alcoholic Hepatitis Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Alcoholic Hepatitis Therapeutic Market Share by Players (2016-2021)
Table 22. Global Top Alcoholic Hepatitis Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alcoholic Hepatitis Therapeutic as of 2020)
Table 23. Ranking of Global Top Alcoholic Hepatitis Therapeutic Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Alcoholic Hepatitis Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Alcoholic Hepatitis Therapeutic Product Solution and Service
Table 27. Date of Enter into Alcoholic Hepatitis Therapeutic Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Type (2016-2021)
Table 31. Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Alcoholic Hepatitis Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Application (2016-2021)
Table 35. Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Alcoholic Hepatitis Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Alcoholic Hepatitis Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Alcoholic Hepatitis Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Alcoholic Hepatitis Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Alcoholic Hepatitis Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Alcoholic Hepatitis Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 67. Alkermes Company Details
Table 68. Alkermes Business Overview
Table 69. Alkermes Alcoholic Hepatitis Therapeutic Product
Table 70. Alkermes Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million)
Table 71. Alkermes Recent Development
Table 72. Conatus pharmaceuticals Company Details
Table 73. Conatus pharmaceuticals Business Overview
Table 74. Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Product
Table 75. Conatus pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million)
Table 76. Conatus pharmaceuticals Recent Development
Table 77. Dainippon sumitomo pharma Company Details
Table 78. Dainippon sumitomo pharma Business Overview
Table 79. Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Product
Table 80. Dainippon sumitomo pharma Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million)
Table 81. Dainippon sumitomo pharma Recent Development
Table 82. Generon corporation Company Details
Table 83. Generon corporation Business Overview
Table 84. Generon corporation Alcoholic Hepatitis Therapeutic Product
Table 85. Generon corporation Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million)
Table 86. Generon corporation Recent Development
Table 87. Immuron limited Company Details
Table 88. Immuron limited Business Overview
Table 89. Immuron limited Alcoholic Hepatitis Therapeutic Product
Table 90. Immuron limited Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million)
Table 91. Immuron limited Recent Development
Table 92. Lupin Laboratories Company Details
Table 93. Lupin Laboratories Business Overview
Table 94. Lupin Laboratories Alcoholic Hepatitis Therapeutic Product
Table 95. Lupin Laboratories Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million)
Table 96. Lupin Laboratories Recent Development
Table 97. Intercept Pharmaceuticals Company Details
Table 98. Intercept Pharmaceuticals Business Overview
Table 99. Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Product
Table 100. Intercept Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million)
Table 101. Intercept Pharmaceuticals Recent Development
Table 102. Teva Pharmaceuticals Company Details
Table 103. Teva Pharmaceuticals Business Overview
Table 104. Teva Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million)
Table 105. Teva Pharmaceuticals Recent Development
Table 106. Sanofi-Aventis Company Details
Table 107. Sanofi-Aventis Business Overview
Table 108. Sanofi-Aventis Alcoholic Hepatitis Therapeutic Product
Table 109. Sanofi-Aventis Revenue in Alcoholic Hepatitis Therapeutic Business (2016-2021) & (US$ Million)
Table 110. Sanofi-Aventis Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alcoholic Hepatitis Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Monoclonal Antibodies Features
Figure 3. Caspase Protease Inhibitor Features
Figure 4. Corticosteroids Features
Figure 5. Hemorheologic Agents Features
Figure 6. Anabolic Steroids Features
Figure 7. Hepatotropic Hormones Features
Figure 8. Sulfhydryl Agents Features
Figure 9. Others Features
Figure 10. Global Alcoholic Hepatitis Therapeutic Market Share by Application: 2020 VS 2027
Figure 11. Hospitals and Clinics Case Studies
Figure 12. Research and Development Case Studies
Figure 13. Alcoholic Hepatitis Therapeutic Report Years Considered
Figure 14. Global Alcoholic Hepatitis Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Alcoholic Hepatitis Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Alcoholic Hepatitis Therapeutic Market Share by Regions: 2020 VS 2027
Figure 17. Global Alcoholic Hepatitis Therapeutic Market Share by Regions (2022-2027)
Figure 18. Global Alcoholic Hepatitis Therapeutic Market Share by Players in 2020
Figure 19. Global Top Alcoholic Hepatitis Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alcoholic Hepatitis Therapeutic as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Alcoholic Hepatitis Therapeutic Revenue in 2020
Figure 21. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Type (2016-2021)
Figure 22. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Type (2022-2027)
Figure 23. North America Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Alcoholic Hepatitis Therapeutic Market Share by Type (2016-2027)
Figure 25. North America Alcoholic Hepatitis Therapeutic Market Share by Application (2016-2027)
Figure 26. North America Alcoholic Hepatitis Therapeutic Market Share by Country (2016-2027)
Figure 27. United States Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Alcoholic Hepatitis Therapeutic Market Share by Type (2016-2027)
Figure 31. Europe Alcoholic Hepatitis Therapeutic Market Share by Application (2016-2027)
Figure 32. Europe Alcoholic Hepatitis Therapeutic Market Share by Country (2016-2027)
Figure 33. Germany Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Alcoholic Hepatitis Therapeutic Market Share by Region (2016-2027)
Figure 43. China Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Alcoholic Hepatitis Therapeutic Market Share by Type (2016-2027)
Figure 51. Latin America Alcoholic Hepatitis Therapeutic Market Share by Application (2016-2027)
Figure 52. Latin America Alcoholic Hepatitis Therapeutic Market Share by Country (2016-2027)
Figure 53. Mexico Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Alcoholic Hepatitis Therapeutic Market Share by Country (2016-2027)
Figure 59. Turkey Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Alkermes Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021)
Figure 63. Conatus pharmaceuticals Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021)
Figure 64. Dainippon sumitomo pharma Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021)
Figure 65. Generon corporation Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021)
Figure 66. Immuron limited Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021)
Figure 67. Lupin Laboratories Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021)
Figure 68. Intercept Pharmaceuticals Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021)
Figure 69. Teva Pharmaceuticals Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021)
Figure 70. Sanofi-Aventis Revenue Growth Rate in Alcoholic Hepatitis Therapeutic Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed


【掲載企業】

Alkermes、Conatus pharmaceuticals、Dainippon sumitomo pharma、Generon corporation、Immuron limited、Lupin Laboratories、Intercept Pharmaceuticals、Teva Pharmaceuticals、Sanofi-Aventis

★調査レポート[世界のアルコール性肝炎治療市場規模・現状・予測2021-2027] (コード:QY21APR0235)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアルコール性肝炎治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆